Drug Use-results survey for Simponi 50mg

Drug Use-results survey for Simponi 50mg - Drug Use-results survey for Simponi 50mg

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015895

Enrollment

3000

Registered

2014-12-15

Start date

2011-09-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with rheumatoid arthritis who are treated with Simponi

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
Safety (Adverse Drug Reaction) Effectiveness (Disease Activity Score 28, Visual Analog Scale)	—

Countries

Japan

Contacts

Public ContactAkiko Yamamoto

Janssen Pharmaceutical K.K. Safety Risk Management Dept.

ayamamot@its.jnj.com03-4411-5173

Outcome results